113 S1686 IS: Saving Kids From Dangerous Drugs Act of 2013 U.S. Senate 2013-11-12 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

II113th CONGRESS1st SessionS. 1686IN THE SENATE OF THE UNITED STATESNovember 12, 2013Mrs. Feinstein (for herself and Mr. Grassley) introduced the following bill; which was read twice and referred to the Committee on the JudiciaryA BILLTo amend the Controlled Substances Act to provide enhanced penalties for marketing controlled substances to minors.

1.

Short title

This Act may be cited as the Saving Kids From Dangerous Drugs Act of 2013.

2.

Offenses involving controlled substances marketed to minors

Section 401 of the Controlled Substances Act (21 U.S.C. 841) is amended by adding at the end the following:(i)

Offenses involving controlled substances marketed to minors

(1)

Unlawful act

Except as authorized under this title, including paragraph (3), it shall be unlawful for any person at least 18 years of age to—(A)knowingly or intentionally manufacture or create a controlled substance listed in schedule I or II that is—(i)combined with a beverage or candy product;(ii)marketed or packaged to appear similar to a beverage or candy product; or(iii)modified by flavoring or coloring; and(B)know, or have reasonable cause to believe, that the combined, marketed, packaged, or modified controlled substance will be distributed, dispensed, or sold to a person under 18 years of age.(2)

Penalties

Except as provided in section 418, 419, or 420, any person who violates paragraph (1) of this subsection shall be subject to—(A)an additional term of imprisonment of not more than 10 years for a first offense involving the same controlled substance and schedule; and(B)an additional term of imprisonment of not more than 20 years for a second or subsequent offense involving the same controlled substance and schedule.(3)

Exceptions

Paragraph (1) shall not apply to any controlled substance that—(A)has been approved by the Secretary under section 505 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355), if the contents, marketing, and packaging of the controlled substance have not been altered from the form approved by the Secretary; or(B)has been altered at the direction of a practitioner who is acting for a legitimate medical purpose in the usual course of professional practice..

3.

Sentencing Guidelines

Pursuant to its authority under section 994 of title 28, United States Code, and in accordance with this section, the United States Sentencing Commission shall review its guidelines and policy statements to ensure that the guidelines provide an appropriate additional penalty increase to the sentence otherwise applicable in Part D of the Guidelines Manual if the defendant was convicted of a violation of section 401(i) of the Controlled Substances Act, as added by section 2 of this Act.